Operational Research for Cryptococcal antigen screening to improve ART survival
- Start Date:
- End Date:
This will be a phased-in, randomized trial design to evaluate the implementation of CRAG screening and pre-emptive antifungal therapy of HIV-infected persons entering ART outpatient treatment. Those who are ART eligible with a CD4=100 cells/µL will have a serum CRAG performed by lateral flow assay. Those who are CRAG positive and asymptomatic will be treated with high dose fluconazole. After 6 months survival and cryptococcal meningitis free survival will be compared between those who are CRAG+ and CRAG negative.
Crime and Obesity
Telling kids to "be more active" won't dent the obesity epidemic if they're afraid to go outside.
Buzz. No Death.
Imagine a mosquito that could not transmit malaria. Marcelo Jacobs-Lorena did. Then he made one.
Why are men lining up to be circumcised in rural Uganda? One cut can dramatically reduce the risk of HIV infection.
Chuka Anude had a great job, but it wasn't enough. He wanted to be a leader. So he came to the Bloomberg School.
In northwest Bangladesh, the JiVitA research project seeks to save infant lives with vitamin A.